Our healthcare & life sciences advisory team brings together a combined experience of over 50 years in healthcare advisory, across lead advisory, financial & commercial diligence, valuation and other strategic consulting services.

With a focused Healthcare and Life-sciences Advisory practice, covering hospitals, med-tech, pharmaceuticals & biotech, we are committed to providing bespoke solutions to address the business and operational issues of our clients as well as help them fuel their strategic growth plans.

We have an extensive experience of working with leading and emerging pharma companies, multi and single-specialty healthcare delivery providers/operators, as well as several players in the domestic and international med-tech space and healthcare focussed PE/VC funds. We also actively advise companies on various cross border transactions.

We understand the drivers and needs of your business and design sector-driven solutions that bring about long-term positive changes to your business while focusing on the growth opportunities.

Lead Advisory – Buy side and Sell side

  • PE/VC: raising finance, exits and strategic buyouts
  • Mergers and Acquisitions
  • Financial analysis and modelling
  • Valuation and negotiation support
  • Deal structuring and documentation

Transaction Advisory

  • Financial and tax due diligence (vendor and acquisition)
  • Commercial due diligence

Valuation

  • Portfolio valuation for PE/VC funds
  • Business valuation
  • Transaction valuation support
  • Litigation valuation
  • Brand and intangible valuation
  • Purchase price allocation as per IFRS, US GAAP etc.

Why Grant Thornton

  • We have a Partner led focused healthcare and life sciences advisory national team with significant experience of over 7 years in transactions in the sector
  • Worked / working with some of the leading hospitals & life sciences companies, single specialty chains, day surgery centers, leading diagnostic service providers and several healthcare-focused private equity funds, in multiple capacities
  • Possess experience in end to end transaction support, including lead advisory, financial, commercial and tax due diligence and valuations. We provide engagement support over the lifecycle of the transaction resulting in the most relevant and credible deal experience in the market
  • Sector focus provides us a deep understanding of the drivers of your business as well as the key challenges faced by the sector, thereby providing you with sound inputs
  • Global network within GTI member firms including a dedicated Global M&A team that focuses only on cross-border transactions. Well connected with team’s specialising in the sector globally to draw inputs from
  • Delivered quality  due diligence support to almost all the leading private equity players for/on their healthcare investments in India
  • Provided valuation support to several leading pharma and healthcare delivery players for internal restructuring, transactions and portfolio valuation needs